A detailed history of Sandhill Capital Partners LLC transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Sandhill Capital Partners LLC holds 392,561 shares of TMDX stock, worth $29.9 Million. This represents 4.57% of its overall portfolio holdings.

Number of Shares
392,561
Previous 434,974 9.75%
Holding current value
$29.9 Million
Previous $65.5 Million 5.93%
% of portfolio
4.57%
Previous 5.2%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$135.68 - $176.11 $5.75 Million - $7.47 Million
-42,413 Reduced 9.75%
392,561 $61.6 Million
Q2 2024

Aug 13, 2024

SELL
$72.62 - $150.62 $21.7 Million - $45 Million
-298,697 Reduced 40.71%
434,974 $65.5 Million
Q1 2024

May 14, 2024

SELL
$70.86 - $89.93 $2.09 Million - $2.66 Million
-29,530 Reduced 3.87%
733,671 $54.2 Million
Q4 2023

Feb 02, 2024

BUY
$36.74 - $81.08 $1.12 Million - $2.48 Million
30,591 Added 4.18%
763,201 $60.2 Million
Q3 2023

Nov 13, 2023

SELL
$53.47 - $96.07 $4.29 Million - $7.71 Million
-80,234 Reduced 9.87%
732,610 $40.1 Million
Q2 2023

Aug 08, 2023

BUY
$66.23 - $88.73 $53.8 Million - $72.1 Million
812,844 New
812,844 $68.3 Million
Q1 2023

May 12, 2023

SELL
$53.63 - $82.33 $11.6 Million - $17.8 Million
-216,133 Reduced 17.95%
987,617 $74.8 Million
Q4 2022

Feb 10, 2023

SELL
$39.08 - $64.29 $5.45 Million - $8.96 Million
-139,413 Reduced 10.38%
1,203,750 $74.3 Million
Q3 2022

Nov 14, 2022

SELL
$31.56 - $55.75 $7.71 Million - $13.6 Million
-244,394 Reduced 15.39%
1,343,163 $56.1 Million
Q2 2022

Aug 10, 2022

SELL
$20.56 - $32.15 $6.64 Million - $10.4 Million
-323,185 Reduced 16.91%
1,587,557 $49.9 Million
Q1 2022

May 16, 2022

BUY
$12.58 - $26.94 $1.32 Million - $2.83 Million
105,224 Added 5.83%
1,910,742 $51.5 Million
Q4 2021

Feb 09, 2022

BUY
$19.16 - $32.68 $7 Million - $11.9 Million
365,473 Added 25.38%
1,805,518 $34.6 Million
Q3 2021

Nov 12, 2021

BUY
$25.92 - $34.51 $275,088 - $366,254
10,613 Added 0.74%
1,440,045 $47.7 Million
Q2 2021

Aug 11, 2021

BUY
$21.63 - $40.07 $5.02 Million - $9.3 Million
232,093 Added 19.38%
1,429,432 $47.4 Million
Q1 2021

May 13, 2021

SELL
$17.75 - $47.82 $942,915 - $2.54 Million
-53,122 Reduced 4.25%
1,197,339 $49.7 Million
Q4 2020

Feb 12, 2021

BUY
$11.91 - $19.9 $1.14 Million - $1.91 Million
96,130 Added 8.33%
1,250,461 $24.9 Million
Q3 2020

Nov 12, 2020

BUY
$13.78 - $18.84 $5.49 Million - $7.51 Million
398,608 Added 52.75%
1,154,331 $15.9 Million
Q2 2020

Aug 13, 2020

SELL
$11.66 - $18.26 $178,106 - $278,921
-15,275 Reduced 1.98%
755,723 $13.5 Million
Q1 2020

May 14, 2020

BUY
$10.5 - $20.2 $365,641 - $703,424
34,823 Added 4.73%
770,998 $9.31 Million
Q4 2019

Feb 13, 2020

BUY
$16.61 - $21.64 $3.99 Million - $5.2 Million
240,149 Added 48.41%
736,175 $14 Million
Q3 2019

Nov 14, 2019

BUY
$20.27 - $28.93 $10.1 Million - $14.4 Million
496,026 New
496,026 $11.8 Million

Others Institutions Holding TMDX

About TransMedics Group, Inc.


  • Ticker TMDX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 31,831,400
  • Market Cap $2.42B
  • Description
  • TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...
More about TMDX
Track This Portfolio

Track Sandhill Capital Partners LLC Portfolio

Follow Sandhill Capital Partners LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Sandhill Capital Partners LLC, based on Form 13F filings with the SEC.

News

Stay updated on Sandhill Capital Partners LLC with notifications on news.